A Study to Assess the Safety and Efficacy of the of the Gastric-retentive AP-CD/LD in Advanced Parkinson's Patients

Clinical trial NCT02605434 · UNKNOWN

Trial details

NCT number: NCT02605434
Sponsor: Intec Pharma Ltd.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Parkinson's Disease

Start date: 2016-03-01
Primary completion: 2019-07-01
Enrollment: 420

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.